ARCUTIS BIOTHERAPEUTIC
10.91
26-十一月-24 08:56:54
15 分钟延时
股票
+0.14
+1.30%
今日范围
10.78 - 11.50
ISIN
N/A
来源
NASDAQ
-
Arcutis’ ZORYVE® (roflumilast) Awarded Best Eczema Treatment by Glamour
13 11月 2024 07:00:00 条件 Nasdaq GlobeNewswire
-
Arcutis Announces Third Quarter 2024 Financial Results and Provides Business Update
06 11月 2024 15:00:00 条件 Nasdaq GlobeNewswire
-
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04 11月 2024 15:00:00 条件 Nasdaq GlobeNewswire
-
23 10月 2024 15:00:00 条件 Nasdaq GlobeNewswire
-
18 10月 2024 07:20:14 条件 Nasdaq GlobeNewswire
-
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04 10月 2024 15:00:00 条件 Nasdaq GlobeNewswire
-
25 9月 2024 00:00:00 条件 Nasdaq GlobeNewswire
-
24 9月 2024 07:00:00 条件 Nasdaq GlobeNewswire
-
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
05 9月 2024 15:00:00 条件 Nasdaq GlobeNewswire
-
Arcutis Completes Enrollment of Phase 1b Alopecia Areata Study Evaluating ARQ-255
05 9月 2024 07:00:00 条件 Nasdaq GlobeNewswire
-
Arcutis to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference
22 8月 2024 07:00:00 条件 Nasdaq GlobeNewswire
-
CORRECTION – Arcutis Announces Second Quarter 2024 Financial Results and Provides Business Update
14 8月 2024 20:00:03 条件 Nasdaq GlobeNewswire
-
Arcutis Announces Second Quarter 2024 Financial Results and Provides Business Update
14 8月 2024 15:00:00 条件 Nasdaq GlobeNewswire
-
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
02 8月 2024 15:00:00 条件 Nasdaq GlobeNewswire
-
Arcutis to Report Second Quarter 2024 Financial Results and Host Conference Call on August 14, 2024
01 8月 2024 15:00:00 条件 Nasdaq GlobeNewswire
-
Arcutis Announces ZORYVE® U.S. Co-promote Agreement with Kowa Pharmaceuticals America, Inc.
29 7月 2024 06:35:00 条件 Nasdaq GlobeNewswire
-
Arcutis Launches ZORYVE® (roflumilast) Cream 0.15% for the Treatment of Atopic Dermatitis
29 7月 2024 06:30:00 条件 Nasdaq GlobeNewswire
- <<
- <
- 1
- >